Longevity

A sweet way to extend lifespan: Sugar-based Lifespan extension therapy: D-Allulose/D-Psicose, a low-calorie sweetener isolated from natural products, may increase life span via up-regulation of its target gene BubR1, 16/March/2018, 6.50 am

A sweet way to extend lifespan: Sugar-based Lifespan extension therapy: D-Allulose/D-Psicose, a low-calorie sweetener isolated from natural products, may increase life span via up-regulation of its target gene BubR1, 16/March/2018, 6.50 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

A sweet way to extend lifespan: Sugar-based Lifespan extension therapy: Rebaudioside A, a natural sweetener  that is 200 times sweeter than sugar is isolated from Stevia rebaudiana, may increase life span via up-regulation of its target gene BubR1, 14/March/2018, 11.23 pm

A sweet way to extend lifespan: Sugar-based Lifespan extension therapy: Rebaudioside A, a natural sweetener  that is 200 times sweeter than sugar is isolated from Stevia rebaudiana, may increase life span via up-regulation of its target gene BubR1, 14/March/2018, 11.23 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

A sweet way to extend lifespan: Sugar-based Life-extension therapy: D-Allose, an aldohexose sugar,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 13/March/2017, 11.34 pm

A sweet way to extend lifespan: Sugar-based Life-extension therapy: D-Allose, an aldohexose sugar,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span by regulating the expression of its target genes, 13/March/2017, 11.34 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1…

read more

Regenerative therapy for improving memory in aged individuals: L-Arginine, a non-essential amino acid, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down regulation of its target genes, 10/March/2017, 12.47 pm

Regenerative therapy for improving memory in aged individuals: L-Arginine, a non-essential amino acid, increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down regulation of its target genes, 10/March/2017, 12.47 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA;  Paul F. Glenn Center for the Biology of…

read more

Lifespan extension therapy: Trehalose, a natural sweetener found in mushrooms among others, may increase life span via up-regulation of its target gene BubR1, 10/March/2018, 6.26 am

Lifespan extension therapy: Trehalose, a natural sweetener found in mushrooms among others, may increase life span via up-regulation of its target gene BubR1, 10/March/2018, 6.26 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: Atrasentan, an experimental drug for anticancer treatment,may increase life span via up-regulation of its target gene BubR1, 10/March/2018, 6.04 am

Lifespan extension therapy: Atrasentan, an experimental drug for anticancer treatment,may increase life span via up-regulation of its target gene BubR1, 10/March/2018, 6.04 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more